Remove Compounding Remove Drug Development Remove Magazine
article thumbnail

Why relationships are key in rare disease patient engagement

pharmaphorum

Real-world data is a vital part of rare disease drug development, but to get a true picture of patients’ unmet needs pharma should take a broader view of their lived experiences, says Xperiome’s Jeremy Edwards. He says he would like to see the industry engaging rare disease patients at every stage of drug development.

article thumbnail

Customs simplified: the need to streamline pharma shipments

Pharmaceutical Technology

Outsourcing is now a fundamental part of drug development and distribution. Tariffs and trade disputes are further compounding this challenge, affecting the cost structure of pharma businesses. Outsourcing is now a fundamental part of drug development and distribution.